The Chicago Entrepreneur

Vaxcyte’s stock dips after biotech completes $1.42 billion stock offering

Vaxcyte Inc.’s stock fell 3% early Friday, after the company completed a stock offering that is expected to generate $1.42 billion in proceeds.

Previous post Borrowers feel ‘hopeless’ as debt relief flip-flops at the whim of those with power over their student loans
Next post MIT and Yale’s New Class Profiles Post Affirmative Action Ban